| Filed On | Filing |
|---|---|
| 13 Oct 2026 |
8-K: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Other Events
The information set forth under Item 8.01 below under the heading “Royalty Pharma Tranche A Loan” is incorporated by reference into this Item 2.03. |
| 01 Oct 2026 |
Form 4: Sandler Alan B., Chief Development Officer
Received 6,000 shares by exercise or conversion ($353K) · Sold 6,309 shares ($1.28M) |
| 29 Sep 2026 |
Form 4: Cislini Jeff, SVP & General Counsel
Sold 765 shares ($159K) |
| 29 Sep 2026 | 144 |
| 28 Sep 2026 |
Form 4: Mancini Anthony, See Remarks
Sold 587 shares ($117K) · Received 3,121 shares by exercise or conversion ($105K) · Sold 3,121 shares ($626K) |
| 25 Sep 2026 | 144 |
| 24 Sep 2026 | 144 |
| 24 Sep 2026 |
Form 4: Anderson Elizabeth M, Director
Received 5,070 shares by exercise or conversion ($5.68K) · Sold 10,143 shares ($1.96M) |
| 22 Sep 2026 |
Form 4: Mancini Anthony, See Remarks
Sold 1,764 shares ($347K) |
| 22 Sep 2026 | 144 |
| 18 Sep 2026 |
Form 4: Mancini Anthony, See Remarks
Sold 1,774 shares ($353K) |
| 18 Sep 2026 |
Form 4: Cislini Jeff, SVP & General Counsel
Sold 3,366 shares ($671K) |
| 18 Sep 2026 | 144 |
| 18 Sep 2026 |
Form 4: Sandler Alan B., Chief Development Officer
Sold 341 shares ($67.9K) |
| 18 Sep 2026 |
Form 4: Anders Jack, Chief Financial Officer
Sold 4,053 shares ($808K) |
| 18 Sep 2026 |
Form 4: Kelsey Stephen Michael, See Remarks
Sold 5,569 shares ($1.11M) |
| 18 Sep 2026 |
Form 4: Horn Margaret A, Chief Operating Officer
Sold 4,967 shares ($990K) |
| 18 Sep 2026 |
Form 4: Goldsmith Mark A, Director
Sold 13,988 shares ($2.79M) |
| 15 Sep 2026 | 144 |
| 15 Sep 2026 | 144 |
Loading...